Showing 2751-2760 of 3135 results for "".
- BTL Announces New EMFACE Facial Devicehttps://modernaesthetics.com/news/btl-announces-new-emface-facial-device/2473183/BTL has announced its latest technology innovation, which the company says is the result of combining many years of institutional knowledge of the simultaneous emission of radio frequency and electromagnetic energies. EMFACE™ utilizes a patented technology of muscle contraction and ski
- Business News: $511M SPAC Merger Deal for Sunevahttps://modernaesthetics.com/news/business-news-511m-spac-merger-deal-for-suneva/2473182/Suneva Medical, Inc. and Viveon Health Acquisition Corp., a special purpose acquisition company (SPAC), are joining forces to form a regenerative aesthetics company. Upon completion of the transaction, the combined company's securities are expected to be traded on the NYSE unde
- Does the "No Surprises Act" Apply to Aesthetic Services?https://modernaesthetics.com/news/does-the-no-surprises-act-apply-to-aesthetic-services/2473180/In a chat thread with colleagues on our mutual trade organizations' message board, there was a question about providing Good Faith Estimates (GFE) for aesthetic procedures under the No Surprises Act. I stated that I didn't think GFEs were required for aesthetic procedures, but a represent
- Obagi Rolls Out The Skintrinsiq System Devicehttps://modernaesthetics.com/news/obagi-rolls-out-the-skintrinsiq-system-device/2473178/Obagi is launching the Skintrinsiq device, its first entry into the complementary skincare device market. The Skintrinsiq system extracts impurities then infuses Obagi skincare products via treatment protocols customized for individual skincare needs. "The uni
- Sculptra Gets New Labelhttps://modernaesthetics.com/news/sculptra-gets-new-label/2473175/A new FDA-approved label for Sculptra® (injectable poly-L-lactic acid (PLLA)) from Galderma includes higher dilution, the addition of immediate use reconstitution, new injection techniques, and the optional addition of lidocaine. Sculptra is the first and only FDA-approved PLLA facial in
- Registration Open for AACS 2022 Annual Meetinghttps://modernaesthetics.com/news/registration-open-for-aacs-2022-annual-meeting/2473170/Registration is open for the American Academy of Cosmetic Surgery (AACS) 2022 Annual Scientific Meeting. Themed “Immerse in Perfection – Advances in Cosmetic Su
- Galderma to Acquire Alastin Skincarehttps://modernaesthetics.com/news/galderma-to-acquire-alastin-skincare/2473169/Galderma is set to acquire Alastin Skincare®, Inc. The world’s largest independent dermatology company has signed a definitive agreement to acquire the specialty aesthetics company dedicated to developing innovative and clinically-tested physician-dispensed skincare products. Financial
- FDA Clears Sofwave for Eyebrows, Sub-Mental, and Neck Facial Areashttps://modernaesthetics.com/news/fda-clears-sofwave-for-eyebrows-sub-mental-and-neck-facial-areas/2473168/Sofwave is now U.S. Food and Drug Administration (FDA)-cleared for lifting the eyebrow and lifting lax submental tissue and neck tissue in people aged 22 or older. In addition, the Sofwave system featuring the Company's proprietary Superb TM (Synchronous Ultrasound Parallel Be
- 1 Million and Counting: Emsculpt Marks Treatment Milestonehttps://modernaesthetics.com/news/1-million-and-counting-emsculpt-marks-treatment-milestone/2473166/The Emsculpt family of products from BTL is the fastest aesthetic device brand to reach one million treatments, as indicated by Medical Insights. According to BTL, which reported the milestone, an average of 21 Emsculpt Classic treatments/unit a
- Gryphon Investors Signs Deal to Aquire Revision Skincarehttps://modernaesthetics.com/news/gryphon-investors-signs-deal-to-aquire-revision-skincare/2473163/The Middle-market private equity firm Gryphon Investors has signed a definitive agreement to acquire Revision Skincare and Goodier Cosmetics, with an anticipating closing date this year. Financial terms of the transaction were not disclosed. Revision Goodier's management team